Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Sijia Lü(Xinjiang Normal University), Zongbi Yi(Wuhan University), Binliang Liu(Central South University), Xin Dong, Chunxiao Li(Peking University), Yunyun Niu, Hongyan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Xia Zhu(Chinese Academy of Fishery Sciences), Lixi Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
The Breast
December 20, 2019
10.1016/j.breast.2019.12.010
Cited by 39

Related Papers

Autophagy Enhancer Carbamazepine Alleviates Memory Deficits and Cerebral Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease
|Current Alzheimer Research|2013|148
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-β Production in an Aged Alzheimer's Disease Transgenic Mouse Model
|Journal of Alzheimer s Disease|2011|114
PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum
|Cell Research|2017|102
MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1
|Oncotarget|2015|96
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
|BMJ|2023|82